Lydon Nicholas
Insider CIK 1639935 · ANAB Director · BPMC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-06-12 | 2024-06-14 | 4,570 | — | $0 | 4,570 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-06-12 | 2024-06-14 | 2,242 | — | $0 | 58,026 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-06-21 | 2023-06-23 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-06-21 | 2023-06-23 | 2,600 | — | $0 | 55,784 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-06-21 | 2022-06-30 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-06-21 | 2022-06-30 | 2,600 | — | $0 | 53,184 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-05-23 | 2022-05-25 | 10,909 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-05-23 | 2022-05-25 | 10,909 | $19.53 | $213.1K | 50,584 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-06-02 | 2021-06-04 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-06-02 | 2021-06-04 | 2,250 | — | $0 | 39,675 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-10-01 | 2020-10-05 | 1,389 | $92.06 | $127.9K | 37,425 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-10-01 | 2020-10-05 | 4,530 | $92.88 | $420.7K | 38,814 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-10-01 | 2020-10-05 | 3,896 | $93.68 | $365.0K | 43,344 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-09-17 | 2020-09-21 | 500 | $80.00 | $40.0K | 47,240 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-07-06 | 2020-07-08 | 600 | $81.02 | $48.6K | 47,740 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-07-06 | 2020-07-08 | 25,407 | $80.44 | $2.04M | 48,340 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-07-02 | 2020-07-06 | 2,825 | $80.13 | $226.4K | 73,747 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-07-01 | 2020-07-06 | 1,300 | $80.21 | $104.3K | 76,572 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-06-24 | 2020-06-26 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-06-24 | 2020-06-26 | 2,250 | — | $0 | 77,872 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-06-23 | 2020-06-25 | 400 | $80.00 | $32.0K | 75,622 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-06-22 | 2020-06-23 | 13,017 | $80.29 | $1.05M | 76,022 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 89,039 | SEC↗ |
| BPMC Blueprint Medicines Corp | G Gift | 2020-05-15 | 2020-05-19 | 20,000 | — | $0 | 87,727 | SEC↗ |
| BPMC Blueprint Medicines Corp | G Gift | 2019-08-19 | 2019-08-21 | 20,000 | — | $0 | 107,727 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 4,875 | — | $0 | 4,875 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 1,312 | — | $0 | 1,312 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-13 | 2019-06-17 | 25,000 | $90.36 | $2.26M | 127,727 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-12 | 2019-06-14 | 300 | $81.96 | $24.6K | 152,727 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-12 | 2019-06-14 | 2,000 | $82.45 | $164.9K | 153,027 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-12 | 2019-06-14 | 5,200 | $83.83 | $435.9K | 155,027 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-12 | 2019-06-14 | 6,300 | $84.66 | $533.4K | 160,227 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-12 | 2019-06-14 | 11,200 | $85.75 | $960.4K | 166,527 | SEC↗ |
| ANAB ANAPTYSBIO INC | A Award deriv | 2019-02-08 | 2019-02-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2018-06-21 | 2018-06-25 | 7,500 | — | $0 | 29,318 | SEC↗ |
| ANAB ANAPTYSBIO INC | S Sale | 2018-04-16 | 2018-04-18 | 10,310 | $85.11 | $877.5K | 291,196 | SEC↗ |
| ANAB ANAPTYSBIO INC | S Sale | 2018-04-16 | 2018-04-18 | 2,600 | $84.18 | $218.9K | 301,506 | SEC↗ |
| ANAB ANAPTYSBIO INC | S Sale | 2018-04-16 | 2018-04-18 | 1,390 | $86.15 | $119.7K | 289,806 | SEC↗ |
| ANAB ANAPTYSBIO INC | S Sale | 2018-04-16 | 2018-04-18 | 2,222 | $90.26 | $200.6K | 271,106 | SEC↗ |
| ANAB ANAPTYSBIO INC | S Sale | 2018-04-16 | 2018-04-18 | 2,803 | $89.42 | $250.6K | 273,328 | SEC↗ |
| ANAB ANAPTYSBIO INC | S Sale | 2018-04-16 | 2018-04-18 | 4,250 | $88.30 | $375.3K | 276,131 | SEC↗ |
| ANAB ANAPTYSBIO INC | S Sale | 2018-04-16 | 2018-04-18 | 9,425 | $87.46 | $824.3K | 280,381 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-28 | 2018-03-02 | 5,527 | $86.92 | $480.4K | 182,340 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-28 | 2018-03-02 | 9,596 | $89.03 | $854.3K | 193,131 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-28 | 2018-03-02 | 5,264 | $88.20 | $464.3K | 187,867 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-28 | 2018-03-02 | 4,613 | $86.35 | $398.3K | 177,727 | SEC↗ |
| ANAB ANAPTYSBIO INC | M Exercise deriv | 2018-02-15 | 2018-02-20 | 16,483 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | M Exercise | 2018-02-15 | 2018-02-20 | 16,483 | $4.55 | $75.0K | 304,106 | SEC↗ |
| ANAB ANAPTYSBIO INC | A Award deriv | 2018-02-02 | 2018-02-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2017-06-21 | 2017-06-23 | 10,909 | — | $0 | 21,818 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-03-14 | 2017-03-16 | 1,400 | $39.72 | $55.6K | 202,727 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-03-14 | 2017-03-16 | 68,600 | $40.06 | $2.75M | 204,127 | SEC↗ |
| ANAB ANAPTYSBIO INC | A Award deriv | 2017-02-24 | 2017-02-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 55,403 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 80,877 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 67,345 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 16,666 | $15.00 | $250.0K | 287,623 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 203,625 | — | $0 | 270,957 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2016-06-23 | 2016-06-27 | 10,909 | — | $0 | 10,909 | SEC↗ |